Assessment of steroid use as a key performance indicator in inflammatory bowel disease—analysis of data from 2385 UK patients

Summary Background Patients with IBD are at risk of excess corticosteroids. Aims To assess steroid excess in a large IBD cohort and test associations with quality improvement and prescribing. Methods Steroid exposure was recorded for outpatients attending 19 centres and associated factors analysed....

Full description

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2019-11, Vol.50 (9), p.1009-1018
Main Authors: Selinger, Christian P., Parkes, Gareth C., Bassi, Ash, Limdi, Jimmy K., Ludlow, Helen, Patel, Pritash, Smith, Melissa, Saluke, Santosh, Ndlovu, Zandile, George, Becky, Saunders, John, Adamson, Mark, Fraser, Aileen, Robinson, Jenna, Donovan, Fiona, Parisi, Ioanna, Tidbury, Jude, Gray, Lynn, Pollok, Richard, Scott, Glyn, Raine, Tim
Format: Article
Language:English
Subjects:
Adrenal Cortex Hormones - therapeutic use
Adult
Aged
Aged, 80 and over
Anti-Inflammatory Agents - classification
Anti-Inflammatory Agents - therapeutic use
Business metrics
Cohort Studies
Corticoids
Corticosteroids
Crohn's disease
Dependence
Exposure
Female
Humans
Inflammatory bowel disease
Inflammatory bowel diseases
Inflammatory Bowel Diseases - diagnosis
Inflammatory Bowel Diseases - drug therapy
Inflammatory Bowel Diseases - epidemiology
Intestine
Male
Middle Aged
Practice Patterns, Physicians' - standards
Practice Patterns, Physicians' - statistics & numerical data
Prognosis
Quality Assurance, Health Care
Quality control
Quality Indicators, Health Care
Steroid hormones
Steroids
Steroids - therapeutic use
Tumor necrosis factor
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Tumor Necrosis Factor-alpha - immunology
Ulcerative colitis
United Kingdom - epidemiology
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background Patients with IBD are at risk of excess corticosteroids. Aims To assess steroid excess in a large IBD cohort and test associations with quality improvement and prescribing. Methods Steroid exposure was recorded for outpatients attending 19 centres and associated factors analysed. Measures taken to avoid excess were assessed. Results Of 2385 patients, 28% received steroids in the preceding 12 months. 14.8% had steroid excess or dependency. Steroid use was significantly lower at ‘intervention centres’ which participated in a quality improvement programme (exposure: 23.8% vs 31.0%, P 
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.15497